Health

COVID-19: EU Still Testing Pfizer Vaccine, Keeps 2021 Forecast

The European Medicines Agency is still reviewing the safety of a Covid-19 vaccine submitted by Pfizer and BionNTech and has not received clinical trial data, EU sources said Monday.

A “rolling review” of several potential vaccines is underway and, for now, Brussels is sticking by its forecast that one may be approved and available “early next year”, one source said.

Earlier, the companies said that ongoing trials had found that their vaccine was 90 percent effective in preventing Covid-19 infections, sending hopes soaring for an end to the epidemic.

The European Medicines Agency (EMA) has begun an expedited procedure to examine potential vaccines, and did nothing to pour cold water on reports of a breakthrough.

But a spokeswoman for the Amsterdam-based agency said they had yet to receive the results of clinical trials.

“Through rolling reviews, EMA can exceptionally evaluate data as it becomes available, ahead of a formal marketing-authorisation application,” she said.

“We evaluated the first batch of data on the vaccine, which came from laboratory studies (non-clinical data).

“The agency is currently assessing a second batch of data which relate to the quality of the vaccine, including data related to its ingredients and the way it is produced.

“Any new data available for this vaccine will be reviewed in the same way. We have not received nor assessed the emerging clinical data at this point and can therefore not comment further.”

Separately, in Brussels, a European source confirmed this and added “any prediction would be risky, but we have good indications that the first vaccine may be available early next year.”

European officials, including the president of the European Commission Ursula von der Leyen have previously used this timeline when talking about a future vaccine.

And Brussels has put funding aside to reserve tens of millions of doses of future vaccines from several companies, including that from US giant Pfizer and its German partner BioNTech.

AFP

admin

Recent Posts

Rep Oseni Rallies Support for Ikogosi Development Projects, Calls for Resilience, Unity

The Chairman of the House Committee on the Federal Road Maintenance Agency (FERMA) and representative…

19 hours ago

Bad Roads: ‘Focus on Message, Not Messenger’ – Nigerians Tell Works Minister, Umahi

The Nigerian Minister of Works, David Umahi, has ignited widespread public reaction following his response…

4 days ago

Oseni Salutes Senator Folarin’s Decades of Service at 61

  Engr. Aderemi Oseni, representing Ibarapa East/Ido Federal Constituency of Oyo State in the House…

6 days ago

Oseni Donates N10m to Support Ibadan’s Mogaji Ile Eke Project

The Chairman, House Committee on Federal Roads Maintenance Agency (FERMA), Engr. Aderemi Oseni has made…

1 week ago

Lead City Varsity Hosts Conference on Leadership, Personality Development

Dr. Ayobami Owolabi, President of the Institute of Personality Development & Customer Relationship Management (IPDCRM),…

1 week ago

Ugandan Court Hands Ex-LRA Commander 40-Year Sentence

  In a historic ruling, a Ugandan court on Friday sentenced former Lord’s Resistance Army…

2 weeks ago